CTI BIOPHARMA Trademark

Trademark Overview

On Wednesday, August 6, 2014, a trademark application was filed for CTI BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the CTI BIOPHARMA trademark a serial number of 86359462. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 17, 2025. This trademark is owned by CTI BIOPHARMA CORP.. The CTI BIOPHARMA trademark is filed in the Education & Entertainment Services category with the following description:

Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders
cti biopharma

General Information

Serial Number86359462
Word MarkCTI BIOPHARMA
Filing DateWednesday, August 6, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 17, 2025
Registration Number5715670
Registration DateTuesday, April 2, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 1, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"BIOPHARMA"
Goods and ServicesConducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders
Description of MarkThe mark consists of a stylized image of a stick figure design to the left hand side of the wording "CTI BIOPHARMA".

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 17, 2025
Primary Code041
First Use Anywhere DateSaturday, June 21, 2014
First Use In Commerce DateSaturday, June 21, 2014

Trademark Owner History

Party NameCTI BIOPHARMA CORP.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCTI BIOPHARMA CORP.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameCTI BIOPHARMA CORP.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events

Event DateEvent Description
Saturday, August 9, 2014NEW APPLICATION ENTERED
Friday, August 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 16, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, August 31, 2014ASSIGNED TO EXAMINER
Sunday, August 31, 2014NON-FINAL ACTION WRITTEN
Sunday, August 31, 2014NON-FINAL ACTION E-MAILED
Sunday, August 31, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 25, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 5, 2015ASSIGNED TO LIE
Thursday, March 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 29, 2015FINAL REFUSAL WRITTEN
Wednesday, April 29, 2015FINAL REFUSAL E-MAILED
Wednesday, April 29, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, October 19, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, October 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 1, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2016TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, April 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 23, 2016DIVISIONAL REQUEST RECEIVED
Thursday, April 14, 2016DIVISIONAL PROCESSING COMPLETE
Friday, April 15, 2016CORRECTED NOA E-MAILED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 22, 2016SOU TEAS EXTENSION RECEIVED
Friday, July 22, 2016SOU EXTENSION 1 FILED
Friday, July 22, 2016SOU EXTENSION 1 GRANTED
Tuesday, July 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 25, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, January 25, 2017SOU EXTENSION 2 FILED
Wednesday, January 25, 2017SOU EXTENSION 2 GRANTED
Friday, January 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 24, 2017SOU TEAS EXTENSION RECEIVED
Monday, July 24, 2017SOU EXTENSION 3 FILED
Monday, July 24, 2017SOU EXTENSION 3 GRANTED
Wednesday, July 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2017SOU EXTENSION 4 FILED
Tuesday, December 5, 2017SOU EXTENSION 4 GRANTED
Thursday, December 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 21, 2018SOU TEAS EXTENSION RECEIVED
Thursday, June 21, 2018SOU EXTENSION 5 FILED
Monday, July 2, 2018SOU EXTENSION 5 GRANTED
Tuesday, July 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 28, 2019TEAS STATEMENT OF USE RECEIVED
Monday, January 28, 2019USE AMENDMENT FILED
Monday, February 4, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 12, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 17, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

biopharma disorders clinical sciences life trials oncology genetic cancer hematology health